146 related articles for article (PubMed ID: 31072639)
1. Discovery of Allosteric Inhibition of Human ATP-Citrate Lyase.
Granchi C
Trends Pharmacol Sci; 2019 Jun; 40(6):364-366. PubMed ID: 31072639
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study.
Jha V; Galati S; Volpi V; Ciccone L; Minutolo F; Rizzolio F; Granchi C; Poli G; Tuccinardi T
J Biomol Struct Dyn; 2021 Jul; 39(11):3996-4004. PubMed ID: 32448086
[TBL] [Abstract][Full Text] [Related]
3. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective.
Granchi C
Expert Opin Ther Pat; 2022 Jul; 32(7):731-742. PubMed ID: 35436171
[TBL] [Abstract][Full Text] [Related]
4. The structure of succinyl-CoA synthetase bound to the succinyl-phosphate intermediate clarifies the catalytic mechanism of ATP-citrate lyase.
Huang J; Fraser ME
Acta Crystallogr F Struct Biol Commun; 2022 Oct; 78(Pt 10):363-370. PubMed ID: 36189720
[TBL] [Abstract][Full Text] [Related]
5. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.
Verberk SGS; Kuiper KL; Lauterbach MA; Latz E; Van den Bossche J
Trends Mol Med; 2021 Dec; 27(12):1095-1105. PubMed ID: 34635427
[TBL] [Abstract][Full Text] [Related]
6. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
[TBL] [Abstract][Full Text] [Related]
7. ACLY-matizing Macrophages to Histone Modification during Immunometabolic Reprogramming.
Williams NC; O'Neill LA
Trends Immunol; 2020 Feb; 41(2):93-94. PubMed ID: 31948874
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-CoA is produced by the citrate synthase homology module of ATP-citrate lyase.
Verstraete K; Verschueren KHG; Dansercoer A; Savvides SN
Nat Struct Mol Biol; 2021 Aug; 28(8):636-638. PubMed ID: 34294920
[No Abstract] [Full Text] [Related]
9. Reply to: Acetyl-CoA is produced by the citrate synthase homology module of ATP-citrate lyase.
Wei X; Marmorstein R
Nat Struct Mol Biol; 2021 Aug; 28(8):639-641. PubMed ID: 34294921
[No Abstract] [Full Text] [Related]
10. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
11. Identification of the citrate-binding site of human ATP-citrate lyase using X-ray crystallography.
Sun T; Hayakawa K; Bateman KS; Fraser ME
J Biol Chem; 2010 Aug; 285(35):27418-27428. PubMed ID: 20558738
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
[TBL] [Abstract][Full Text] [Related]
13. ATP citrate lyase: A central metabolic enzyme in cancer.
Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
[TBL] [Abstract][Full Text] [Related]
14. Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases.
Liang JJ; Zhou XF; Long H; Li CY; Wei J; Yu XQ; Guo ZY; Zhou YQ; Deng ZS
Bioorg Chem; 2024 Jan; 142():106933. PubMed ID: 37890210
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.
Zang Y; Tai L; Hu Y; Wang Y; Sun H; Wen X; Yuan H; Dai L
J Chem Inf Model; 2022 Jun; 62(12):3123-3132. PubMed ID: 35679529
[TBL] [Abstract][Full Text] [Related]
16. Lycopene ameliorates hyperlipidemia via potentiation of AMP-activated protein kinase and inhibition of ATP-citrate lyase in diabetic hyperlipidemic rat model.
Elseweidy MM; Elawady AS; Sobh MS; Elnagar GM
Life Sci; 2022 Nov; 308():120934. PubMed ID: 36075470
[TBL] [Abstract][Full Text] [Related]
17. 3-fluoro-3-deoxycitrate: a probe for mechanistic study of citrate-utilizing enzymes.
Rokita SE; Srere PA; Walsh CT
Biochemistry; 1982 Aug; 21(16):3765-74. PubMed ID: 6215936
[TBL] [Abstract][Full Text] [Related]
18. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle.
Verschueren KHG; Blanchet C; Felix J; Dansercoer A; De Vos D; Bloch Y; Van Beeumen J; Svergun D; Gutsche I; Savvides SN; Verstraete K
Nature; 2019 Apr; 568(7753):571-575. PubMed ID: 30944476
[TBL] [Abstract][Full Text] [Related]
19. Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase.
Ismail A; Mokhlis HA; Sharaky M; Sobhy MH; Hassanein SS; Doghish AS; Salama SA; Mariee AD; Attia YM
Pathol Res Pract; 2022 Dec; 240():154211. PubMed ID: 36401980
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure-Activity Relationship and Inhibition Profiles.
Wang P; Hou T; Xu F; Luo F; Zhou H; Liu F; Xie X; Liu Y; Wang J; Guo Z; Liang X
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
